Evidence map›Paper›PMID 42028469›Full record

ArticleAnnals of vascular diseases2026

A Preliminary Investigation into the Effects of Immunosuppressive Therapy on Outcomes of Endovascular Aneurysm Repair.

Yohei Yamamoto, Toru Kikuchi, Kazuki Tsukuda, Natsuho Maekawa, Ai Kazama, Yoshiki Wada, Tsuyoshi Ichinose, Toshifumi Kudo

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Annals of vascular diseases, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Yohei YamamotoDivision of Vascular Surgery, Department of Cardiovascular Surgery, Institute of Science Tokyo, Tokyo, Japan.
Toru KikuchiDivision of Vascular Surgery, Department of Cardiovascular Surgery, Institute of Science Tokyo, Tokyo, Japan.
Kazuki TsukudaDivision of Vascular Surgery, Department of Cardiovascular Surgery, Institute of Science Tokyo, Tokyo, Japan.
Natsuho MaekawaDivision of Vascular Surgery, Department of Cardiovascular Surgery, Institute of Science Tokyo, Tokyo, Japan.
Ai KazamaDivision of Vascular Surgery, Department of Cardiovascular Surgery, Institute of Science Tokyo, Tokyo, Japan.
Yoshiki WadaDivision of Vascular Surgery, Department of Cardiovascular Surgery, Institute of Science Tokyo, Tokyo, Japan.
Tsuyoshi IchinoseDivision of Vascular Surgery, Department of Cardiovascular Surgery, Institute of Science Tokyo, Tokyo, Japan.
Toshifumi KudoDivision of Vascular Surgery, Department of Cardiovascular Surgery, Institute of Science Tokyo, Tokyo, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objectives: This study aimed to evaluate the short- and long-term outcomes of endovascular aneurysm repair (EVAR) for abdominal aortic aneurysms (AAAs), with a particular focus on the impact of immunosuppressive therapy. Methods: The authors retrospectively reviewed the institutional data of patients with AAAs who underwent EVAR between 2008 and 2023. Results: A total of 307 consecutive patients underwent elective EVAR for AAA. Of these, 26 patients (8.5%) were receiving immunosuppressive therapy (IT group). Patients in the IT group had a significantly higher incidence of early postoperative complications than those in the non-IT group (42.3% vs. 17.4%). The mean follow-up period was 40.7 ± 33.6 months. The cumulative incidence of sac shrinkage was similar between the groups, whereas the cumulative incidence of sac expansion was significantly higher in the IT group. The rates of reintervention and open aneurysmorrhaphy were also significantly higher in the IT group. The use of immunosuppressive therapy was one of the significant risk factors for late sac expansion (hazard ratio, 4.66, 95% confidence interval, 2.12-10.23). Overall survival was similar regardless of immunosuppressive therapy status. Conclusions: Immunosuppressive therapy may be associated with an increased risk of early postoperative complications and late sac expansion in patients undergoing EVAR.

Indexed as

abdominal aortic aneurysmendovascular aneurysm repairimmunosuppressive therapypostoperative complication

Identifiers

PMID42028469
PMCPMC13100662

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.